Cancer management and advisory firm Integrated Oncology Network (ION) joins Comvest, Capricorn and Atlantic Health Group in backing cancer treatment business SightLine.
California-based Integrated Oncology Network (ION) invested an undisclosed amount in Texas-based Cancer treatment specialists SightLine Health and its subsidiaries, on 2 December, as part of a strategic partnership.
Venture firms Capricorn Investment and Comvest are also backers of SightLine. JMP Securities advised SightLine on the deal.
Jeffrey Goffman, executive chairman of ION, said: "We are excited by the opportunity to partner with TJ Farnsworth [SightLine’s chief executive] and the SightLine management team with a focus on continiuing to integrate…
